Dieses Ergebnis aus Supplemental Index kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Phase III Study of Doxorubicin/Cyclophosphamide With Concomitant Versus Sequential Docetaxel As Adjuvant Treatment in Patients With Human Epidermal Growth Factor Receptor 2--Normal, Node-Positive Breast Cancer: BCIRG-005 Trial.

Title:	Phase III Study of Doxorubicin/Cyclophosphamide With Concomitant Versus Sequential Docetaxel As Adjuvant Treatment in Patients With Human Epidermal Growth Factor Receptor 2--Normal, Node-Positive Breast Cancer: BCIRG-005 Trial.
Authors:	Eiermann, Wolfgang^{1,2,3,4,5,6,7,8,9,10,11,12,13,14,15} w.eiermann@gmx.net; Pienkowski, Tadeusz^{1,2,3,4,5,6,7,8,9,10,11,12,13,14,15}; Crown, John^{1,2,3,4,5,6,7,8,9,10,11,12,13,14,15}; Sadeghi, Saeed^{1,2,3,4,5,6,7,8,9,10,11,12,13,14,15}; Martin, Miguel^{1,2,3,4,5,6,7,8,9,10,11,12,13,14,15}; Chan, Arlene^{1,2,3,4,5,6,7,8,9,10,11,12,13,14,15}; Saleh, Mansoor^{1,2,3,4,5,6,7,8,9,10,11,12,13,14,15}; Sehdev, Sandeep^{1,2,3,4,5,6,7,8,9,10,11,12,13,14,15}; Provencher, Louise^{1,2,3,4,5,6,7,8,9,10,11,12,13,14,15}; Semiglazov, Vladimir^{1,2,3,4,5,6,7,8,9,10,11,12,13,14,15}; Press, Michael^{1,2,3,4,5,6,7,8,9,10,11,12,13,14,15}; Sauter, Guido^{1,2,3,4,5,6,7,8,9,10,11,12,13,14,15}; Lindsay, Mary-Ann^{1,2,3,4,5,6,7,8,9,10,11,12,13,14,15}; Riva, Alessandro^{1,2,3,4,5,6,7,8,9,10,11,12,13,14,15}; Buyse, Marc^{1,2,3,4,5,6,7,8,9,10,11,12,13,14,15}; Drevot, Philippe^{1,2,3,4,5,6,7,8,9,10,11,12,13,14,15}; Taupin, Henry^{1,2,3,4,5,6,7,8,9,10,11,12,13,14,15}; Mackey, John R.^{1,2,3,4,5,6,7,8,9,10,11,12,13,14,15}
Source:	Journal of Clinical Oncology. 10/10/2011, Vol. 29 Issue 29, p3877-3884. 8p.
Database:	Supplemental Index